Dianthus Therapeutics Banner

Event Details

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
Press Release

Bank of America 2025 Health Care Conference

May 14, 2025 5:35 PM EDT